Cadila Healthcare Limited (Zydus Cadila) has posted a 29 per cent rise in its consolidated net profit on a year-on-year (YoY) basis at Rs 587 crore for the first quarter ended June 30, 2021. The company had registered a net profit of Rs 454 crore in the said quarter last year.
The company's consolidated revenue from operations rose by 14 per cent to Rs 3,917 crore in Q1 of FY 2021-22 from Rs 3,424 crore in Q1 of FY 2020-21.
Zydus Cadila's India business which consists of human formulations and consumer wellness and contributed to 50 per cent of consolidated revenues during